Prana Biotechnology Limited (NASDAQ:PRAN) shares hit a new 52-week low on Thursday . The company traded as low as $1.56 and last traded at $1.57, with a volume of 376 shares. The stock had previously closed at $1.75.
Separately, ValuEngine raised Prana Biotechnology from a “hold” rating to a “buy” rating in a report on Thursday, November 1st.
The firm has a market capitalization of $15.39 million, a price-to-earnings ratio of -2.37 and a beta of 0.07.
Prana Biotechnology Company Profile (NASDAQ:PRAN)
Prana Biotechnology Ltd. engages in the development of therapy treatment for neurodegenerative disease. It includes research and development of treatments for Alzheimer’s and Huntington’s disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.
Recommended Story: Fundamental Analysis and Choosing Stocks
Receive News & Ratings for Prana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.